End-to-End Biologic & Injectable Manufacturing for Programs That Must Succeed

Dharma Biologics | Bengaluru, India

Therapeutic development today is not constrained by imagination.
It is constrained by execution.

Across biologics and advanced therapeutics, molecules rarely fail because the underlying biology was flawed. They fail because manufacturing, formulation, regulatory strategy, analytics, delivery, and scale were never aligned as one coherent system. Decisions were optimized locally and paid for globally. Problems appeared late, when timelines were compressed, capital was committed, and regulators were already watching.

Dharma Biologics exists precisely at that intersection.

We are built to support therapeutic programs where failure is expensive, timelines are unforgiving, and regulatory scrutiny is inevitable. From early expression and process development through clinical supply and commercial manufacturing, we design therapeutic systems that remain intact under scale, inspection, and real-world use.

As the highest-quality CDMO in India—and a core execution node within a deeply capitalized, technically aligned CDMO Network—Dharma Biologics offers sponsors something rare in modern drug development: completeness without chaos. Every modality, every scale, every regulatory expectation is addressed through a single execution philosophy grounded in discipline, traceability, and systems thinking.

Our work is recognized not through marketing awards, but through outcomes: repeat sponsor programs, clean inspections, successful tech transfers, and long-term supply relationships that endure beyond a single molecule. In complex therapeutics, trust is earned operationally.

Therapeutics Without Fragmentation

Most therapeutic programs suffer from fragmentation early—long before sponsors realize it.

Expression systems are optimized without regard for downstream purification behavior.
Formulation decisions ignore delivery and device constraints.

Combination-product considerations are deferred until late-stage development.
Regulatory documentation is assembled reactively instead of designed intentionally.

These fractures feel manageable in early phases. They become existential risks later.

Dharma Biologics eliminates fragmentation by treating therapeutics as manufacturable systems, not isolated scientific achievements. We connect upstream biology, downstream processing, formulation, device compatibility, analytics, quality, and regulatory strategy from day one—so programs move forward without losing coherence.

Our therapeutic capabilities span biologics, injectables, combination products, and emerging modalities, all executed through a unified framework that preserves intent across phases, facilities, and scales.

Biologic Therapeutics Platforms

Dharma Biologics supports a broad spectrum of biologic therapeutic modalities, with deep specialization in microbial and mammalian expression systems optimized for scalability, robustness, and regulatory clarity. We design platforms that behave predictably over time, under stress, and across volumes.

Monoclonal Antibodies & Antibody-Derived Therapeutics

We support full-length monoclonal antibodies, antibody fragments, bispecifics, Fc-fusions, and engineered protein scaffolds across CHO, HEK, and microbial systems where scientifically and commercially appropriate.

Capabilities include:

• Stable cell line development and clone selection with long-term genetic integrity
• Fed-batch, intensified, and productivity-balanced culture strategies
• Downstream purification train design emphasizing impurity clearance and yield robustness
• Aggregation, charge variant, and product-related impurity control
• High-concentration and device-compatible formulation readiness

We design antibody programs not just to express well, but to survive scale, validation, and commercial reality.

Recombinant Proteins, Enzymes & Cytokines

From hormones and growth factors to immune-modulating proteins and engineered enzymes, Dharma Biologics supports therapeutic proteins that require tight control over folding, activity, and purity.

Our capabilities include:

• E. coli and yeast expression platforms engineered for stability and campaign length
• Inclusion body and soluble expression strategies, selected intentionally rather than by habit
• Refolding process design with scalability and yield recovery in mind
• Activity-driven analytical development, not just purity metrics
• Scalable purification architectures aligned with cost-of-goods and regulatory expectations

We treat enzymatic activity and biological function as primary quality attributes—not secondary checks.

Fusion Proteins & Engineered Constructs

Complex fusion proteins impose unique stability and manufacturability challenges. Dharma designs expression and purification strategies that respect structural fragility while enabling scale.

mRNA & Nucleic-Acid Enabled Therapeutics

Dharma Biologics supports therapeutic programs leveraging mRNA and enzymatically produced nucleic-acid payloads—not as isolated technologies, but as part of integrated therapeutic systems.

Our capabilities include:

• Enzymatic mRNA synthesis support
• Capping, tailing, and purity control
• Enzyme and reagent manufacturing
• Analytical characterization
• Integration with delivery-ready drug product strategies

We understand that mRNA therapeutics succeed or fail on process reproducibility, not novelty.

Therapeutic Drug Substance Manufacturing

Dharma Biologics provides cGMP drug substance manufacturing for clinical and commercial therapeutic programs.

Our infrastructure supports:

• Microbial fermentation at multiple scales
• Mammalian cell culture for biologics
• Flexible campaign-based manufacturing
• Dedicated and multi-product suites
• Global tech transfer within the CDMO Network

Scale-up is treated as a structural transition—not a leap of faith.

Therapeutic Drug Product & Injectables

Therapeutic success increasingly depends on delivery. Dharma Biologics is a leader in complex injectable drug products, supporting therapies that demand precision.

Sterile Injectables

• Liquid and lyophilized formulations
• Small and large molecule injectables
• Sensitive biologics requiring low shear
• Narrow therapeutic index products

High-Concentration Biologics

We design therapeutic formulations that balance stability, viscosity, and deliverability—critical for self-administered biologics.

Aseptic Fill-Finish

• Isolator-based aseptic lines
• Vials, prefilled syringes, cartridges
• Device-ready filling strategies
• Global regulatory alignment

Combination Products for Therapeutic Delivery

Many modern therapeutics are inseparable from their delivery systems.

Dharma Biologics offers full therapeutic combination product development, including:

• Autoinjectors
• Fixed and variable dose pens
• Prefilled delivery systems
• Device assembly and final packaging
• Global combination product compliance

Drug, device, and patient use are treated as one regulatory object.

Analytical & Regulatory Foundations

Therapeutic manufacturing fails without defensible data.

Dharma Biologics provides:

• Formulation science
• Analytical method development
• Validation and transfer
• Stability programs (real-world stress)
• Extractables & leachables
• Comparability and bridging studies

All analytics are designed to survive inspection—not just support development.

Clinical to Commercial Continuity

Therapeutic programs often stumble at transition points. Dharma designs continuity deliberately.

We support:

• Preclinical and IND-enabling supply
• Phase I–III clinical manufacturing
• Commercial launch and lifecycle supply
• Post-approval change management
• Global distribution via CDMO Network partners

Sponsors do not need to “start over” at each phase.

Therapeutic Rescue & Program Recovery

Because of our breadth and system-level view, Dharma Biologics is frequently engaged to rescue stalled therapeutic programs.

Common scenarios include:

• Failed tech transfers
• Unscalable processes
• Regulatory setbacks
• Device-formulation mismatches

We diagnose first. Then rebuild what matters.

Why Dharma Biologics for Therapeutics

Therapeutic manufacturing today requires more than capacity. It requires judgment, restraint, and architectural thinking.

Dharma Biologics brings:

• One of the most comprehensive therapeutic capability stacks in India
• Deep backing and execution leverage via the CDMO Network
• Teams experienced across biologics, injectables, and combination products
• Regulatory-by-design execution
• Manufacturing systems built for longevity

We are not chasing volume.
We are building therapies that last.

From Bengaluru, Built for Patients

ಚಿಕಿತ್ಸೆ ಒಂದು ವಿಜ್ಞಾನ. ಅದರ ನಿರ್ವಹಣೆ ಧರ್ಮ.

Email our team at info@dharmabiologics.com